Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach

Psychopharmacology

Volumn 136, Issue 3, 1998, Pages 284-290

  Clifford, Jeremiah J ^a   Waddington, John L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

D3 antagonist; D3 dopamine receptor; Ethological assessment; GR 103691; Nafadotride; Spontaneous behaviour; U99194A

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 4' ACETYL N [4 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]BUTYL]BIPHENYL 4 CARBOXAMIDE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NAFADOTRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; EATING; GROOMING; LOCOMOTION; MALE; MASTICATION; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; SNIFFING; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BEHAVIOR, ANIMAL; BIPHENYL COMPOUNDS; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; GROOMING; HALOPERIDOL; INDANS; MALE; MOTOR ACTIVITY; NAPHTHALENES; PIPERAZINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STEREOTYPED BEHAVIOR;

EID: 0031890614     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050567     Document Type: Article

References (43)

1. 2 receptor antagonist L-741,626. Br J Pharmacol 119 : 1491-1497
2. 3 receptor agonist. (+)-PD 128907, in the rat. Neuropharmacology 35 : 285-294
3. 3 dopamine receptors. Neuropsychopharmacology 12 : 335-345
4. 2-like agonists. Neuropharmacology 32 : 509-510
5. 1-like dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C. Psychopharmacology 113 : 45-50
6. 3 receptor ligand. Eur J Pharmacol 249 : R9-R10
7. 3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine. Psychopharmacology 124 : 231-240
8. 1-like" dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 116 : 2120-2126
9. 2-like" agonist RU 24213. Psychopharmacology 124 : 40-49
10. 1-like" dopamine receptor agonists. Pharmacol Biochem Behav 58 : 551-558
11. Devoto P, Collu M, Muntoni AM, Pistis M, Serra G, Gessa GL, Diana M (1995) Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse 20 : 153-155
12. 3 receptor in the rat brain. Neuroscience 65 : 731-745
13. 3 receptor in the presynaptic regulation of dopamine release but not synthesis. Eur J Pharmacol 308 : 261-269
14. 3 agonist, 7-OH-DPAT. reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Brain Res 681 : 1-7
15. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J Pharmacol Exp Ther 275 : 899-913
16. 3 receptors. Eur J Pharmacol 272 : R1-R3
17. Jaber M, Robinson SW, Missale C, Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35 : 1503-1519
18. 3-preferring agonist 7-OH-DPAT on motor behaviours and place conditioning. Psychopharmacology 122 : 351-357
19. 2 receptors in the shell of the nucleus accumbens; jaw movements. Eur J Pharmacol 308 : 227-234
20. 2 receptors in the shell of the nucleus accumbens: turning behaviour. Eur J Pharmacol 308 : 235-241
21. 3 receptor binding affinities. Eur J Pharmacol 277 : 209-214
22. 3 receptor agonists. 7-OH-DPAT. and quinpirole, on yawning, stereotypy, and body temperature in rats. Pharmacol Biochem Behav 52 : 503-508
23. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur J Pharmacol 275 : R7-R9
24. 2 dopamine receptors by 7-OH-DPAT. Synapse 24 : 60-64
25. 3 receptors. Eur J Pharmacol 249 : R5-R6
26. 2 agonist LY 163502. Psychopharmacology 98 : 245-250
27. 3 receptor. Bioorg Med Chem Lett 5 : 219-222
28. 4 receptors. J Pharmacol Exp Ther 277 : 186-192
29. Patel J, Trout SJ, Palij P, Whelpton R, Kruk ZL (1995) Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens. Br J Pharmacol 115 : 421-426
30. 3 agonist PD 128907. J Pharmacol Exp Ther 275 : 1355-1366
31. 2 receptors. NeuroReport 6 : 329-332
32. 3 receptor antagonist. activates locomotion in rodents. J Pharmacol Exp Ther 275 : 1239-1246
33. 3) as a target for neuroleptics. Nature 347 : 146-151
34. Stahle L (1992) Do autoreceptors mediate dopamine agonist-induced yawning and suppression of exploration? A critical review. Psychopharmacology 106 : 1-13
35. 3 receptors. Eur J Pharmacol 277 : 151-158
36. Storey VJ, Middlemiss DN, Reavill C (1995) Effect of haloperidol and (-)sulpiride on dopamine agonist-induced hypoactivity. Neuropharmacology 34 : 449-455
37. 3 receptors. Eur J Pharmacol 263 : 235-243
38. 3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci 17 : 2519-2530
39. 3 receptors. Neuropharmacology 36 : 787-792
40. Van den Busse M (1993) Effects of 7-hydroxy-N.N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats. Eur J Pharmacol 243 : 169-177
41. 5 dopamine receptor mechanisms in relation to antipsychotic activity. In : Barnes TRE (ed) Antipsychotic drugs and their side effects. Academic Press, London, pp 65-85
42. 2-like" receptors. Prog Neuro-Psychopharmacol Biol Psychiatry 19 : 811-831
43. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm [Gen Sect] 94 : 11-19